| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2001;71:1809-1812
© 2001 The Society of Thoracic Surgeons
a Department of General and Thoracic Surgery, Christian-Albrechts-University Hospital, Kiel, Germany
Accepted for publication February 14, 2001.
Address reprint requests to Dr Schulze, Department of General and Thoracic Surgery, Christian-Albrechts-University, Arnold-Heller-Str 8, 24105 Kiel, Germany
e-mail: maren_schulze{at}hotmail.com
Background. For effective palliation of patients with malignant pleural effusion due to advanced neoplastic disease, any proposed treatment should have low procedure-related mortality and morbidity.
Methods. The clinical outcome of 119 thoracoscopies in 101 patients (56 women, 45 men), from 42 to 91 years of age (mean, 68 ± 9 years) with malignant pleural effusions was evaluated in a retrospective study. Video-assisted thoracoscopy (VATS) talc pleurodesis was done in 105 instances, and a pleuroperitoneal shunt was performed 14 times as an alternative when complete expansion of the lung could not be achieved due to tumor implants on the visceral pleura.
Results. The VATS talc pleurodesis resulted in clinically significant improvement of dyspnea in 92.2% of the patients. Thirty-day mortality was 2.8% and morbidity was 2.8%. The mean duration of postoperative survival was 6.7 months. Recurrent pleural effusion occurred in 5.7% of patients after a mean interval of 6 months. Clinical relief of dyspnea was obtained in 73% of the patients treated with pleuroperitoneal shunts. Thirty-day mortality in this group was 21% and morbidity was 14.3%. The mean duration of survival was 4.2 months.
Conclusions. The VATS talc pleurodesis is appropriate for palliation of patients with malignant pleural effusions and should be performed once the diagnosis has been confirmed. Patients with lungs trapped by visceral carcinomatosis may benefit from placement of a pleuroperitoneal shunt as an alternative.
This article has been cited by other articles:
|
|
 |
|
  R. A Qureshi, S. L Collinson, R. J Powell, P. O Froeschle, and R. G Berrisford Management of Malignant Pleural Effusion Associated with Trapped Lung Syndrome Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 120 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Warren, R. Kalimi, L. M. Khodadadian, and A. W. Kim Management of Malignant Pleural Effusions Using the Pleurx Catheter Ann. Thorac. Surg., March 1, 2008; 85(3): 1049 - 1055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Warren, A. W. Kim, and M. J. Liptay Identification of clinical factors predicting Pleurx (R) catheter removal in patients treated for malignant pleural effusion Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 89 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rodriguez-Panadero, J. P. Janssen, and P. Astoul Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur. Respir. J., August 1, 2006; 28(2): 409 - 422. [Full Text] [PDF]
|
|
|
|
|
|
C. Tan, A. Sedrakyan, J. Browne, S. Swift, and T. Treasure The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 829 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Dresler, J. Olak, J. E. Herndon II, W. G. Richards, E. Scalzetti, S. B. Fleishman, K. H. Kernstine, T. Demmy, D. M. Jablons, L. Kohman, et al. Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion Chest, March 1, 2005; 127(3): 909 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Crnjac, M. Sok, and M. Kamenik Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 432 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Kvale, M. Simoff, and U. B. S. Prakash Palliative Care Chest, January 1, 2003; 123(1_suppl): 284S - 311S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bernard, R. B. de Dompsure, O. Hagry, and J. P. Favre Early and late mortality after pleurodesis for malignant pleural effusion Ann. Thorac. Surg., July 1, 2002; 74(1): 213 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cardillo, F. Facciolo, L. Carbone, M. Regal, F. Corzani, A. Ricci, M. Di Martino, and M. Martelli Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 302 - 306. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
